Pedro Beltran

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pedro Beltran:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 357,177 26 Aug 2025 Direct

Insider Reports Filed by Pedro Beltran

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HLXB BridgeBio Oncology Therapeutics, Inc. 26 Aug 2025 1 $0 4 Chief Scientific Officer 28 Aug 2025, 16:39
HLXB BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 0 $0 3 Chief Scientific Officer 18 Aug 2025, 17:07